Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7727/wimj.2014.154 http://scihub22266oqcxt.onion/10.7727/wimj.2014.154 C4696647!4696647!26360676     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       West+Indian+Med+J 2015 ; 64 (2): 71-5 Nephropedia Template TP {{tp|p=26360676|t=2015. Evaluation of Interleukin-10 Levels in Patients Diagnosed with Chronic Hepatitis |pdf=|usr=}}{{26360676}} gab.com Text Evaluation of Interleukin-10 Levels in Patients Diagnosed with Chronic Hepatitis JO: West Indian Med J http://www.kidney.de/pget.php?&tw=1&pmid=26360676 #FOAvip Objective:: One of the most important factors playing a role in chronic hepatitis B pathogenesis is cytokine release and one of the cytokines with anti-inflammatory characteristic is interleukin-10 (IL-10). The aim of the present study is to examine IL-10 levels in patients with chronic hepatitis B. Subjects and Methods:: Sixty-three patients with chronic hepatitis B disease who had not received any antiviral treatment were included in the study. Serum IL-10 level was investigated by enzyme-linked immunosorbent assay (ELISA) method. In the control group, 25 healthy individuals with mean age similar to the patient population were included. Control and patient groups were compared and data were statistically analysed. Results:: Interleukin-10 levels of 25 patients with hepatitis B virus (HBV) DNA levels between 2000 and 20 000 IU/mL were compared with those of 25 subjects in the control group, and the level in the chronic hepatitis B group was statistically significantly higher (p < 0.05). Interleukin-10 levels of 38 patients with HBV DNA > 20 000 IU/mL were statistically significantly higher than those in the control group. When chronic hepatitis B patients were compared among themselves, IL-10 levels increased as HBV DNA levels increased. Also, when IL-10 levels of hepatitis B ?e? antigen (HBeAg) positive patients were compared with those of HBeAg negative patients, the difference was not statistically significant. Conclusion:: It is believed that decreasing IL-10 levels by various methods would have significant contributions in disease progression and treatment. Moreover, IL-10 level may be an important marker in HBeAg seroconversion and evaluation of treatment response. Twit Text FOAVip Evaluation of Interleukin-10 Levels in Patients Diagnosed with Chronic Hepatitis ????West Indian Med J http://www.kidney.de/pget.php?&tw=1&pmid=26360676 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26360676 #FOAvip English Wikipedia <ref>{{Cite pmid|26360676}}</ref> Evaluation of Interleukin-10 Levels in Patients Diagnosed with Chronic Hepatitis #MMPMID26360676 Özgüler M; Akbulut H; Akbulut A West Indian Med J 2015[Mar]; 64 (2): 71-5 PMID26360676show ga Objective:: One of the most important factors playing a role in chronic hepatitis B pathogenesis is cytokine release and one of the cytokines with anti-inflammatory characteristic is interleukin-10 (IL-10). The aim of the present study is to examine IL-10 levels in patients with chronic hepatitis B. Subjects and Methods:: Sixty-three patients with chronic hepatitis B disease who had not received any antiviral treatment were included in the study. Serum IL-10 level was investigated by enzyme-linked immunosorbent assay (ELISA) method. In the control group, 25 healthy individuals with mean age similar to the patient population were included. Control and patient groups were compared and data were statistically analysed. Results:: Interleukin-10 levels of 25 patients with hepatitis B virus (HBV) DNA levels between 2000 and 20 000 IU/mL were compared with those of 25 subjects in the control group, and the level in the chronic hepatitis B group was statistically significantly higher (p < 0.05). Interleukin-10 levels of 38 patients with HBV DNA > 20 000 IU/mL were statistically significantly higher than those in the control group. When chronic hepatitis B patients were compared among themselves, IL-10 levels increased as HBV DNA levels increased. Also, when IL-10 levels of hepatitis B ?e? antigen (HBeAg) positive patients were compared with those of HBeAg negative patients, the difference was not statistically significant. Conclusion:: It is believed that decreasing IL-10 levels by various methods would have significant contributions in disease progression and treatment. Moreover, IL-10 level may be an important marker in HBeAg seroconversion and evaluation of treatment response. äEvaluation of Interleukin-10 Levels in Patients Diagnosed with Chronic(epmc).pdf DeepDyve Pubget Overpricing